Wright State University

CORE Scholar
Browse all Theses and Dissertations

Theses and Dissertations

2015

Na+/K+ Pump and Cl--coupled Na+ and K+ co-transporters in
Mouse Embryonic Fibroblasts lacking the Tuberous Sclerosis
Complex TSC1 and TSC2 genes.
Jasser Ali S. Alzhrani
Wright State University

Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all
Part of the Pharmacology, Toxicology and Environmental Health Commons

Repository Citation
Alzhrani, Jasser Ali S., "Na+/K+ Pump and Cl--coupled Na+ and K+ co-transporters in Mouse Embryonic
Fibroblasts lacking the Tuberous Sclerosis Complex TSC1 and TSC2 genes." (2015). Browse all Theses
and Dissertations. 2036.
https://corescholar.libraries.wright.edu/etd_all/2036

This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has
been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE
Scholar. For more information, please contact library-corescholar@wright.edu.

Na+/K+ Pump and Cl--coupled Na+ and K+ co-transporters in Mouse Embryonic
Fibroblasts lacking the Tuberous Sclerosis Complex TSC1 and TSC2 genes.

A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science

By

JASSER ALI S ALZHRANI
Bachelor of Pharmacy, King Khalid University, Saudi Arabia, 2008

2015
Wright State University

WRIGHT STATE UNIVERSITY
GRADUATE SCHOOL
July 31, 2015

I HEREBY RECOMMEND THAT THESIS PREPARED UNDER MY SUPERVISION
BY Jasser Ali S Alzhrani ENTITLED Na+/K+ Pump and Cl--coupled Na+ and K+ cotransporters in Mouse Embryonic Fibroblasts lacking the Tuberous Sclerosis Complex
TSC1 and TSC2 genes. BE ACCEPTED IN PARTIAL FULLFILMENT OF THE
REQUIREMENTS FOR THE DEGREE OF Master of Science.
___________________________
Norma Adragna, Ph.D.
Thesis Advisor
____________________________
Jeffrey B. Travers, M.D., Ph.D.
Chair, Department of
Pharmacology and Toxicology
Thesis Committee
___________________________
Norma Adragna, Ph.D.
___________________________
Peter Lauf, M.D.
___________________________
Jeffrey B. Travers, M.D., Ph.D.
___________________________
Robert E. W. Fyffe, Ph.D.
Vice President for Research and
Dean of the Graduate School

Abstract

Alzhrani, Jasser Ali. M.S. Department of Pharmacology and Toxicology, Wright
State University, 2015. Na+/K+ Pump and Cl--coupled Na+ and K+ cotransporters in Mouse
Embryonic Fibroblasts lacking the Tuberous Sclerosis Complex 1 (TSC1) and Tuberous
Sclerosis Complex 2 (TSC2) genes.
The tuberous sclerosis complex 1 and 2 (TSC1 and TSC2) genes and their
products hamartin and tuberin, respectively, are involved in several regulatory cellular
mechanisms, including the mTOR pathway that is important for proliferation, cell
migration, and protein synthesis. In addition, it has been suggested that this pathway plays
a role in regulating Na+-K+-2Cl- and K+-Cl- cotransporters (NKCC and KCC,
respectively) [41, 42, 43]. Therefore, the TSC1 and TSC2 genes are expected to play a
significant role in regulating cell volume, and K+ and Cl- homeostasis. This study tests the
hypothesis that the TSC1 and TSC2 genes, which control cell processes through the
mTOR pathway, are important for the function of the Na+/K+ pump (NKP), Na+,K+,2Cland K+,2Cl- cotransporters (KCC and KCC, respectively) and for the maintenance of
intracellular K+ (Ki ) content in mouse embryonic fibroblasts (MEF) cells. The cellular
models are wild type (WT) and knockouts (KO) of the TSC1 or TSC2 genes, TSC1-KO
and TSC2-KO, respectively. K+ homeostasis was assessed through the activities of NKP,
NKCC and KCC determined by rubidium (Rb+, a K+ congener) influx and Ki content in
the presence and absence of the NKP-inhibitor ouabain, the NKCC-inhibitor bumetanide
and by Cl--dependent Rb+ influx via KCC. Optimal ouabain and bumetanide
concentrations were obtained from the dose-response curves of Rb+ influx and Ki content
inhibition toward these compounds. In support of the hypothesis, the main findings
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indicate that absence of the TSC1, and especially, the TSC2 gene, which are associated
with depression of the mTOR pathway [4, 5, 8], leads to accelerated cell proliferation and
migration, and abnormal activities of all the transporters tested revealing the importance
of the TSC1 and TSC2 gene products, hamartin and tuberin, respectively, in cellular K+
homeostasis in MEF cells. Moreover, abnormalities in ion transport of TSC2-KO cells is
commensurate with the pathological manifestation and incidence of tuberous sclerosis
complex in the human population. These findings also uncover potential targets for more
efficient therapy.
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1.

Introduction

Most cellular functions crucially depend on cell volume. In addition, the structure
and function of molecules, and especially of macromolecules such as enzymes, are altered
by hydration [1]. The cellular membrane is highly permeable to water and is responsive to
changes in the intracellular or extracellular osmolality. The cell membrane’s permeability
to Na+, K+ and Cl- ions is orders of magnitude lower than that to water Therefore, in order
to maintain a stable cell volume, all cells express various transport proteins for Na+, K+ and
Cl- across the cell membrane [1, 2].

A brief overview of cell volume regulatory mechanisms will be given here. When
cells are exposed to several osmolalities such as hypotonic, isotonic or hypertonic, they
may undergo volume changes and become swollen, normal or shrunken, respectively.
Swollen cells may undergo regulatory volume decrease (RVD) by releasing ions,
particularly activation of volume-sensitive Cl- and K+ channels and K+- Cl- cotransport
(KCC). Shrunken cell may undergo regulatory volume increase (RVI) by taking up ions,
particularly through the Na+/H+ exchanger, Na+- K+- 2Cl- co-transporter (NKCC), and nonselective cation channels [1, 2] (Fig. 1).
We explore in this study the characteristics of the Na+/K+ Pump and Cl--coupled
Na+ and K+ co-transporters (NKCC and KCC) in mouse embryonic fibroblasts (MEFs)
lacking the tuberous sclerosis complex-1 (TSC1) and -2 (TSC2) genes. The cell models
used are wild type (WT), TSC1-KO, and TSC2-KO. Before providing a more detailed
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description of the study, a brief introduction about TSC 1 and 2, the mammalian target of
rapamycin (mTOR) complex 1 and 2, NKP, NKCC, and KCC will be presented.

Figure 1 - Effectors involved in regulatory volume decrease (RVD) and regulatory
volume increase (RVI) [32]. The main effectors in RVI in most cell types are Na+/H+
exchangers (NHEs), the Na+-K+-2Cl−Cotransporters (NKCCs), anion exchange (AE),
hypertonicity-induced cation channels (HICCs), and Na-dependent transporters for
organic osmolytes. However, the main effectors in RVD are swelling-activated
Cl− channels (Icl,vol), swelling-activated K+ channels (Ik,vol), anion exchange (AE), the K+Cl− cotransporters (KCCs), and organic osmolyte efflux pathways.
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1.1.

Tuberous sclerosis complex 1 (TSC1) and 2 (TSC2)

The tuberous sclerosis complex (TSC) is a multisystem tumor suppressor [3, 4] and
its genetic autosomal dominant aberration causes non-malignant tumors to form in multiple
organs, such as brain, kidney, heart, skin and lungs. TSC abnormalities usually cause
neurologic disorders such as mental problems (retardation), epilepsy, delays in cognitive
development, and autism. In addition to neurological disorders, other manifestation of
tuberous sclerosis include facial angiofibromas, pulmonary lymphangiomyomatosis, and
renal angiomyolipomas [3].

The severity and incidence of TSC can vary between patients and is inherited from
a spontaneous genetic mutation or from one parent suffering from the disease. Affected
parents will have half of their children most likely inheriting TSC. Either the TSC1 or TSC2
genes need to be affected for the manifestation of the disease [3, 4].

The heterodimeric complex that TSC1 and TSC2 proteins form is considered an
essential integrator of numerous pathways that are involved in controlling mTOR, and
particularly mTORC1 activity [4, 5]. The TSC1 gene is located on chromosome 9 and its
open reading frame (ORF) encodes the 130 kDa protein TSC1 (hamartin). This protein has
1164 amino acids. On the other hand, the TSC2 gene encodes the 200 kDa protein TSC2
(tuberin), consisting of 1807 amino acids, and the gene is positioned on chromosome 16
[5]. Both activating and inhibitory phosphorylation events at particular amino acid residues
are the main regulators of the TSC1 and TSC2 proteins activity [3] (Fig. 2).
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Figure 2 - Structure of TSC1 and TSC2. TSC1 (hamartin) interacts with the N-terminal
418 amino acids (aa) of the 1807 aa long tuberin through a 138 aa specific region within
the N-terminal half of its 1164 amino acids. [3].

TSC2 contains a C-terminal GTPase activating protein (GAP) domain. This domain
stimulates GTPase activity toward GDP-Rheb, which means that when the GTPase is
activated by TSC2, it converts GTP-Rheb to GDP-Rheb. This conversion inhibits
mTORC1; whereas when Rheb is in its GTP bound form it is an activator of mTORC1 [9,
10] (Fig. 3). The complex TSC1-TSC2 is inhibited by Protein kinase B (PKB/AKT) which
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is a serine/threonine protein kinase that plays an important role in such as apoptosis, cell
proliferation, cell migration, and transcription. This inhibition occurs through
phosphorylation of TSC2 by AKT on 2-5 sites, although the mechanism at the molecular
level is still unknown because the activity of GAP is not significantly affected by the
various phosphorylation events [7, 8]. TSC1 prevents TSC2 from degradation, so it acts as
a stabilizer of TSC2 (tuberin) [9, 10]. The adenosine monophosphate-dependent protein
kinase (AMPK) usually activates the complex by phosphorylating only 2 residues of TSC2
[11] (Fig. 3).

1.2.

Mammalian Target of Rapamycin (mTOR)

There are several names for mammalian (mechanistic) target of rapamycin (mTOR)
such as FK506-binding protein 12-rapamycin-associated protein 1 (FRAP1). mTOR is a
serine/threonine protein kinase that forms two complexes, each with specific functions.
These complexes are mTORC1 and mTORC2 and are encoded by the mTOR gene [3, 5].
mTOR regulates the most important cellular functions that have direct role in cell survival
such as cell growth, motility, proliferation, transcription, and protein synthesis [12].
Activation and function of mTORC1 and mTORC2 are affected in different ways by the
localization of each protein because both localize to different subcellular compartments
[13].

M-TORC1 is considered to be a sensor for energy, nutrition, and
reduction/oxidation. It regulates protein synthesis, and is composed of different proteins,
mTOR, RAPTOR, mLST8, G protein beta subunit-like (GβL), and most importantly, it is
5

highly sensitive to rapamycin [5] (Fig. 3). Growth factors, insulin, serum, and amino acids,
stimulate the activity of mTORC1. In contrast, mTORC2 consists of mTOR, Rictor,
mLST8, GβL and mSIN1 and it is considered as an essential controller of the cytoskeleton
[14] (Fig. 3).

M-TORC2 also phosphorylates Akt at the serine residue S473, therefore influencing
survival and metabolism [15]. Akt phosphorylation leads to a second phosphorylation,
specifically at a threonine residue T308 by phosphoinositide-dependent protein kinase 1
(PDK1). These two phosphorylation events cause full activation of Akt [16, 17] (Fig. 3).
The major difference between mTORC1 and mTORC2 is that mTORC1 is acutely and
precisely inhibited by rapamycin, whereas rapamycin’s effects on mTORC2 are more
variable. Thus to produce an inhibitory effect, the drug requires chronic administration [5].

6

Figure 3 - PI3K–Akt–mTOR signaling [6]. The phosphatidylinositol 3'-kinase–Akt–
mammalian target of rapamycin (PI3K–Akt–mTOR) pathway is shown in Figure 3.
Energy or amino acid depletion, hypoxia, calcium homeostasis, rapamycin, and 5amino4-imidazolecarboxamide ribose (AICAR) are the most important points in this pathway
[6]. Abbreviations in this figure are phosphatidylinositol 3'-kinase–Akt– mammalian
target of rapamycin (PI3K–Akt–mTOR); 5 amino-4-imidazolecarboxamide ribose
(AICAR); eukaryotic initiation factor (eIF); Eukaryotic initiation factor 4E (eIF4E);
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eIF4E binding protein (4E-BP); 4F cap-binding complex (eIF4); AMP-activated kinase
(AMPK); mitogen-activated protein kinase-interacting kinase 1 (Mnk1);
phosphoinositide-dependent protein kinase 1 (PDK1); phosphatidylinositol-4,5bisphosphate (PtdIns(4,5)P2); phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3);
regulatory associated protein of TOR (raptor); rapamycin-insensitive companion of
mTOR (rictor); ribosomal protein S6 (S6); p70S6 kinase (S6K); tuberous sclerosis
complex (TSC).

The mechanism of mTOR inhibition by rapamycin is by association to intracellular
FK506 binding protein (FKBP12) to form the FKBP12-rapamycin complex. This complex
binds to an mTOR domain and this binding process causes inhibition of the mTOR activity.
The most important information is that rapamycin inhibits mTORC1 in acute doses thus
providing the ultimate favorable effects of the drug. However, rapamycin has a complex
effect on mTORC2 because it inhibits it only in certain cell types and under extended
exposure. Furthermore, the mTOR complex incorporates growth factors (IGF-1 and IGF2), insulin, and amino acids which are considered up-stream’s input pathways [18].

The mTORC1 signaling, which is commonly present in normal cells, inhibits
insulin signaling by a negative feedback effect to monitor and limit the signaling of Akt.
The mTORC1-S6K1 signaling leads to attenuation of PI3K activation downstream of
insulin and the insulin receptor substrate proteins, IRS1 and IRS2. However, in cells
responding to chronic activation of mTORC1, such as those lacking a functional TSC1-
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TSC2 complex, this mechanism of negative feedback inhibits the signaling of Akt affecting
its downstream pathways involved in cell survival and proliferation [4, 5].

1.3.

Na+-K+ pump (NKP), Na+-K+-2Cl- cotransport (NKCC), and K+-Cl-

cotransport (KCC)

A)

Na+/K+ Pump (NKP)
The Na+/K+ Pump (sodium-potassium pump) promotes active transport of Na+ and

K+ ions with expenditure of adenosine tri-phosphate (ATP) as cellular energy. NKP is
localized in the cell membrane of most cell types and pumps three sodium ions outside of
the cell and two potassium ions inside. This pump is responsible for creating ionic gradients
whereby cells maintain a steady-state characterized by high concentrations of intracellular
K+ and low concentrations of Na+, and it is not considered an anti-porter because both K+
and Na+ are moving against their concentration gradients. NKP, discovered in the 1950s by
a Danish scientist, Jens Christian Skou, helps control the resting membrane potential,
regulate cellular volume, and most importantly, functions as an integrator to regulate the
mitogen-activated protein kinases (MAPK), intracellular calcium, and reactive oxygen
species (ROS) [1, 19].
In the operational cycle of NKP, three Na+ ions bind to the pump and one ATP
molecule induces a conformational change which in turn moves the ions through the pump.
One phosphate group from ATP remains bound to the channel, the Na+ ions are released on
the other side of the membrane and the new conformation of NKP acquires high affinity
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for K+ which binds to NKP for translocation to the intracellular compartment [1, 19]. This
binding is also causing a conformational change in NKP making it to release the phosphate
group into the cytoplasm. This process allows NKP to change to its original conformation
and as a result, the K+ ions will be released into the cell. In its normal conformation, NKP
has a high affinity for Na+ ions but it is only when these ions bind to the pump that another
cycle is initiated. The movement of Na+ and K+ against their concentration gradients, i.e.
from low to high concentrations is only possible by constant consumption of ATP by the
pump [1, 2, 19].
NKP is a heterotrimer containing three subunits: α, β, and γ [20]. The alpha subunit
has a molecular mass of 112 kDa, is considered a multispanning membrane protein, and is
responsible for the transport properties of the enzyme. The α-subunit contains the binding
sites for ATP, cations, and ouabain [21].
There are four α-subunits which are α1, α2, α3, and α4 in animal cells, the α2 subunit
is the more abundantly expressed and is the most sensitive to ouabain. However, in humans,
α1 is the most sensitive to this drug. The β-subunit is a polypeptide of 40-60 kDa molecular
weight, and crosses the plasma membrane. This subunit is crucial for the activity of the
Na+/K+ ATPase [20-22]. A third protein, the γ-subunit, serves as a pump regulator [20, 21].
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B)

Na+-K+-2Cl- Co-transport (NKCC)

The membrane-bound NKCC protein plays a critical role in variety of epithelial
process, namely absorption and secretion. Beside that NKCC promotes bidirectional
transport of Na+, K+, and 2 Cl- ions. NKCCs are strongly involved in cell volume and cell
cycle regulation. Two NKCC isoforms are currently known. While NKCC2 seems to be
present restrictively in the kidney, NKCC1, the house-keeping form, is present in almost
all cells [20, 22, 28, 29].

There are two different genes (SLC12A2 and SLC12A1) encoding NKCC1 and
NKCC2, respectively, see Table 1. NKCC transports Na+, K+ and Cl-, and can be blocked
by bumetanide, a loop diuretic. NKCC is not driven by a membrane voltage because it is
electroneutral requiring Na+, K+, and 2Cl- to be present simultaneously on the same side of
the cell membrane to be transported in or out of the cells, depending on the ionic gradients
[20, 22, 29]. One ion increases the affinity for the other ions to bind to NKCC when a Na+,
K+, or Cl- ion is binding to the cotransport. More specifically Na+ binds first and then Cl-,
followed by K+ and a second Cl- externally. According to the “gliding symmetry model”,
internally, the Na+ is released first and then the first Cl-, followed by the K+ and finally by
the second Cl- [48]. In other words, ions depend on each other to increase the binding site
affinity for the remaining ions. NKCC is activated by phosphorylation and deactivated by
de-phosphorylation. Phosphorylation of NKCC is mediated by protein kinase C (PKC),
protein kinase A (PKA), with no lysine kinase (WNK), and Ste20-related proline-alaninerich kinase (SPAK) [34], whereas de-phosphorylation is mediated by protein phosphatases.
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Moreover, the concentrations of ions such as Cl-, Na+, Ca2+, K+, and Mg2+ directly affect
NKCC activity [20, 22, 28-30].

Gene

Species

Gene Symbol

NKCC1

Mouse

Slc12a2

NKCC2

Mouse

Slc12a1

Table 1 - Genes encoding the Na+-K+-2Cl- cotransporters.

C)

K+-Cl- Co-transport (KCC)
KCCs promote electroneutral K+ and Cl- cotransport and are involved in the Na+-

independent K+ transport into or out of the cell, depending on the ionic gradient. KCCs
preserve intracellular Cl- and K+ homeostasis, and ultimately maintain cell volume [20, 22,
30, 31].
The Cl--dependent K+ transport system was first recognized in sheep and fish red
blood cells (RBCs) as a swelling-activated K+ flux [26, 27, 49, 63, 64, 65]. KCCs have four
protein isoforms KCC1 to KCC4 and are encoded by four genes SLC12A4 to 7
respectively, possessing splice variants in each isoform. The KCC1 gene is located on
chromosome 16.q22.1, and its ORF translates a 1085 amino acids protein that fulfills housekeeping function by regulating volume homeostasis in most tissues [36, 37, 65]. KCC2,
located on chromosome 20, occurs in two spliced variants KCC2a and KCC2b. KCC2b,
which is only present in the brain, whereas the second and longer variant KCC2a occurs
not only in the brain but also in other tissues such as the lens and myocardium [20, 22, 26,
12

27, 36, 37, 65] . The third isoform is KCC3 and it is located on chromosome 15.q13. It is
usually found in skeletal muscle, brain, heart, pancreas and kidney. KCC3 has two major
isoforms, KCC3a which has 1150 amino acids, and KCC3b that has 1099 amino acids, both
mainly expressed in the kidney [20, 22, 36, 37].

The last isoform, KCC4 which has 1083 amino acids, located on chromosome 5p15,
and is expressed in different tissues such as thymus, spleen, spinal cord, brain, bone
marrow, pancreas, liver, skeletal muscle, lung, and the heart. KCCs function can be
appreciated when the extracellular medium becomes hyposmotic, inducing water to enter
the cell and causing an increase in cell volume. This activates volume-sensitive K+ and Clchannels and the KCCs, which extrude K+ and Cl- ions and water in order to bring the
volume of the cell back to its original volume [20, 22, 23, 65]. Along with regulating cell
volume, KCCs have been found to be involved in numerous pathologies, cell migration,
and cell growth [38]. KCCs also play important roles in sickle cell disease, cardiovascular
diseases, and tumor biology [33, 61, 62, 63, 64, 65].

2.

Hypothesis and Specific Aims

2.1.

Background for hypothesis

The two functionally important genes TSC1 and TSC2 in MEFs are positioned on
chromosomes 9q34 and 16p13.3, respectively, and encode the 130 kDa hamartin and 200
kDa tuberin proteins, respectively [3, 4]. MEFs TSC1-KO and TSC2-KO cells have high
mTORC1 activity [4, 5] that may lead to activation of NKCC [41, 42] and deactivation of
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KCC [43, 44] as we expected. Therefore, NKCC’s and KCC’s activities should be increased
and decreased with respect to WT cells. Our studies showed activation of NKCC through
increased Rb+ (K+) influx and deactivation of KCC through decreased Rb+ (K+) influx.
Based on these data, we propose the following hypothesis.

2.2.

Hypothesis

The TSC1 and TSC2 genes, which control cell processes through the mTOR
pathway, are important for K+ homeostasis and transport through the Na+/K+ Pump (NKP),
Na+-K+-Cl- (NKCC) and K+-Cl- (KCC) cotransports in mouse embryonic fibroblasts
(MEFs).

I)

Specific Aim 1
Determine the optimal conditions for K+ movements requiring metabolic energy

(Na+/K+ pump) to assess the role of the TSC1 and TSC2 genes and the mTOR pathway on
K+ homeostasis. This will be accomplished by determination of the optimal ouabain
concentration for Rb+ influx and Ki content in WT, TSC1-KO, and TSC2-KO MEF cells.

II)

Specific Aim 2
Determine the optimal conditions for K+ movements through pathways indirectly

dependent on metabolic energy (Na+-K+-Cl- and K+-Cl- cotransport) to assess the role of
the TSC1 and TSC2 genes and the mTOR pathway on K+ homeostasis. This will be
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accomplished by determination of the optimal bumetanide concentration for Rb + influx and
Ki content in WT, TSC1-KO, and TSC2-KO MEF cells.

III)

Specific Aim 3
Determine K+ movements under physiological conditions to assess the role of the

TSC1 and TSC2 genes and the mTOR pathway on K+ homeostasis and to determine
whether they behave as expected for adult Mouse cells. This will be accomplished by
characterization of Rb+ (K+) influx and Ki content in the presence and absence of inhibitors
of NKP, NKCC, and KCC at their optimal concentrations in WT, TSC1-KO and TSC2KO
MEF cells.

3.

Materials and Methods

3.1.

Cell Models

These cell models were provided by Dr. Kristopher T. Kahle, M.D. Ph.D. from
Harvard Medical School. Wild type (WT) MEF cells were used as controls. These cells
possess non tumorigenic characteristics [39], normal cell size and become confluent in
about 4 days, according to our observations. TSC1-KO and TSC2-KO MEF cells are used
as a model of increased mTORC1 activity and S6K expression, accelerated cell
proliferation and growth, and are tumorigenic [3]. According to our observations, these
cells become confluent in about 2 days and are of larger size than WT cells.
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3.2.

Chemicals

Chemicals used in this study were: From Fisher Scientific: sodium chloride (NaCl),
potassium chloride (KCl), magnesium chloride (MgCl2), sucrose, sodium hydroxide
(NaOH), D-glucose, 70% perchloric acid (70% PCA), bicinchonic acid (BCA) protein
assay reagents, and Tri-hydroxyamino methane (Tris) free base. Magnesium gluconate was
from Sigma-Aldrich (St. Louis, MO). Chemicals from J.T.Baker Chemical Co (Center
valley, PA) were: calcium chloride (CaCl2), anhydrous and (4-(2-hydroxyethyl)1piperazine ethane sulfonic acid (HEPES) free acid. High purity rubidium chloride (RbCl)
99.9% and amidosulfonic acid (sulfamic acid, S) were purchased from Alfa Aesar (Ward
Hill, MA); Cesium chloride (CsCl) from Life technologies (Carlsbad, CA) and calcium
gluconate from Acros Organics (NJ).

3.3.

Inhibitors

Ouabain octahydrate was from Calbiochem (San Diego, CA) and bumetanide was
from Sigma-Aldrich (St. Louis, MO).

3.4.

Solutions for flux studies

Washing solutions

Balanced salt solution with sodium chloride (BSS-NaCl) (mM): 20 Hepes-Tris, 5
KCl, 2 CaCl2, 1 MgCl2, 10 glucose and NaCl, pH 7.4, 37 °C, 300 mOsM.
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Balanced salt solution with sodium gluconate (BSS-Na+ gluconate) (mM): 20
Hepes-Tris, 5 K+ gluconate, 2 Ca-gluconate, 1 Mg-gluconate, 10 glucose and Na+gluconate, pH 7.4, 37 °C, 300 mOsM.

Pre-incubation solutions

Balanced salt solution with sodium chloride and bovine serum albumin (BSS-NaClBSA) (mM): 20 Hepes-Tris, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 0.1 % BSA and NaCl,
pH 7.4, 37 °C, 300 mOsM.
Balanced salt solution with sodium gluconate and bovine serum albumin (BSS-Na+
gluconate-BSA) (mM): 20 Hepes-Tris, 5 K+ gluconate, 2 Ca gluconate, 1 Mg gluconate, 10
glucose, 0.1 % BSA and Na+ gluconate, pH 7.4, 37 °C, 300 mOsM.

Flux solutions

Balanced salt solution with rubidium chloride, sodium chloride, and bovine serum
albumin (BSS-RbCl-NaCl-BSA) (mM): 20 Hepes-Tris, 10 RbCl, 2 CaCl2, 1 MgCl2, 10
glucose, 0.1 % BSA and NaCl, pH 7.4, 37 °C, 300 mOsM.

Balanced salt solution with rubidium sulfamate, sodium gluconate, and bovine
serum albumin (BSS-RbS-Na+ gluconate-BSA) (mM): 20 Hepes-Tris, 10 Rb+ sulfamate, 2
Ca gluconate, 1 Mg gluconate, 10 glucose, 0.1 % BSA and Na+ gluconate, pH 7.4, 37 °C,
300 mOsM.
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Final wash solution

10 mM of 3-(N-Morpholino) propane sulfonic acid (MOPS)-Tris, MgCl2, pH 7.4,
37 °C, 300 mOsM.
Rb+ Extraction

5 % perchloric acid, 4 mM CsCl

Protein dissolution

1M NaOH

3.5.

Cell cultures

Mouse embryonic fibroblasts (MEFs) WT, TSC1-KO, and TSC2-KO were cultured
in Dulbecco's Modified Eagle (DMEM) high glucose medium + L-glutamine + 110 mg/L
sodium pyruvate (Life Technologies, Catalog No.11995-073) supplemented with 10 %
premium fetal bovine serum (FBS) (Atlanta Biologicals, Catalog No.S11150), 100 units/ml
penicillin (Hyclone, Catalog No. SV30010), 100 µg/mL streptomycin (Hyclone, Catalog
No. SV30010) in a humidified incubator with 5 % CO2 at 37 °C. Washing buffer 1X
phosphate buffer solution (PBS) (8 g NaCl + 0.2 g KCl + 1.44 g Na2HPO4 + 0.24 g
KH2PO4 dissolved in 1000 ml deionized H2O, pH 7.4) and 0.5 % TrypsinEDTA as to
remove adherent cells from a culture surface (Life Technologies, Catalog No.15400-054).
Cell freezing was done in dimethyl sulfoxide (DMSO, Life Technologies, Catalog
No.D8418-50) at a concentration of 10 % of the freezing medium.
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3.6.

BCA Protein Assay
Proteins were determined by the bicinchoninic acid (BCA) assay, BCA™,

consisting of two reagents, Protein Assay Reagent A (50 parts) and B (1 part), and is a
colorimetric assay that detects proteins by changing color from green to purple [24].
Proteins in the NaOH extract were determined by adding 12.5 µl aliquot to each well of a
96-well microplate (Life Technologies, catalog # 23252) by using an electronic pipette. The
96-well plate was incubated for 30 min at 37 °C and cooled down for 10 min at RT
following quantification by using a Labsystems MultiskanMCC/340 plate reader, according
to the manufacturer’s instructions.

3.7.

Ion Flux Studies

Ion fluxes were determined according to previously published protocols [25, 26, 27]
with some modifications. Cells were grown to 85 % confluence in 12-well plates. WT,
TSC1-KO, and TSC2-KO MEFs were removed from the incubator, the culture medium
was aspirated, cells were washed three times with 1mL of 300 mOsM BSS-NaCl or BSSNa+ gluconate and then equilibrated in BSS-BSA-NaCl or BSS-BSA-Na+ gluconate, pH
7.4, 37 °C for 10 min, thereafter supernatants were removed and then exposed to prewarmed flux media BSS-BSA-RbCl or BSS-BSA-RbS for pre-determined time points (2.5
min to 10 min). Thereafter, cells were washed with washing solution at room temperature
(RT) to block Rb+ influx or Ki loss. Cellular Rb+ and K+ were extracted after cell lysis by
exposing them for 15 min to ice cold 5 % PCA + 4 mM CsCl, the remaining solution was
aspirated and protein was extracted by dissolving the attached cells in 1 M NaOH. Rb+ and
19

K+ were measured by atomic emission and absorption spectrophotometry, respectively
using a Perkin Elmer 5000 Atomic Absorption Spectrophotometer. Protein was determined
by the BCA assay [24] as described above. Rb+ uptake or Ki content were calculated in
nmoles/mg protein as a function of time. Where indicated, ouabain (2 mM) and bumetanide
(20 µM) were added to the flux media to block NKP and NKCC, respectively. The ouabainand the bumetanide-sensitive Rb+ influx in Cl- medium are defined as NKP and NKCC,
respectively, whereas KCC is defined as the (ouabain + bumetanide)-insensitive Cl-dependent Rb+ influx and was obtained by subtracting the Rb+ influx in Cl- medium minus
that in non-Cl- medium (sulfamate or gluconate replacement) containing the two inhibitors
.

3.8.

Statistical Analysis

STATISTIX 7 software, (Graphpad Software, La Jolla CA) and (Analytical
software, Tallahassee FL) from Graphpad Prism 5. These programs were used to determine
statistical significance by one-way ANOVA, Wilcoxon signed rank test, Kruskal-Wallis
ANOVA, and paired or unpaired t-test. Graphs, diagrams, and charts were plotted using
Origin 7 software and Origin Pro 8.5 Student Version (Origin Labs, Northampton MA).
Data were considered statistically significant for p-values < 0.05.

4.

Results

The purpose of this study was to understand the role of the TSC1 and TSC2 genes
and their control of the mTOR signaling pathway on K+ homeostasis. To this end, we used
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cellular models lacking each of the genes and their respective controls, i.e. WT, TSC1-KO
and TSC2-KO MEF cells, and determined the function of key transporters known to be
involved in the maintenance of K+ and cellular volume homeostasis, and in cell migration
and proliferation. The transporters are the Na+/K+ pump and the Cl--coupled Na+ and K+
co-transporters, i.e. NKP, NKCC and KCC. In addition, the TSC1 and TSC2 genes and
their products hamartin and tuberin, respectively, control cell processes through the mTOR
pathway which is important for cell migration, proliferation, and protein synthesis.
Therefore, we proposed that the TSC1 and TSC2 genes and the mTOR pathway play a
significant role in regulating NKP, NKCC and KCC. Thus, as we hypothesized, the TSC1
and TSC2 genes are expected to play a significant role in regulating cell K+ and Clhomeostasis and cellular volume. We assessed K+ homeostasis through the activities of
NKP, NKCC and KCC determined by rubidium (Rb+, a K+ congener) influx and Ki content
in the presence and absence of the NKP inhibitor ouabain, the NKCC inhibitor bumetanide
and by the Cl--dependent Rb+ influx via KCC.

The results are presented with a logic dictated by the scant information available for
these cell models regarding the conditions under which to determine Rb+ influx and Ki
content; this information was mostly borrowed from knowledge of other cultured cells.
Because of the novelty of our studies, we determined the parameters in question in the
absence and presence of inhibitors under different conditions to learn whether MEF cells
behave like adult murine cells (Specific Aims 1-3). It was also necessary to determine the
optimal concentrations of the inhibitors ouabain and bumetanide to measure Rb+ influx and
Ki content in MEF cells (Specific Aims 1 and 2). Lastly, the characterization of Rb+ (K+)
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influx and Ki content was done under physiological conditions applying the knowledge
gained in the preceding studies to determine whether the TSC1 and TSC2 genes are
determinants of K+ homeostasis through the mTOR pathway in MEF cells (Specific Aim
3).

4.1.

Rb+ influx and Ki content in WT, TSC1-KO and TSC2-KO in MEF cells in the

absence of inhibitors.

Previous studies in MEF cells provide information on ion transport and cell
migration. For instance, iron homeostasis is regulated by mTOR through modulation of the
transferrin receptor 1 (TfR1) stability and by altering cellular iron transport [50]. Inversin
controls cell migration processes through transcriptional regulation of genes that control
cytoskeletal organization and ion transport [51]. Presenilin expression affects copper and
zinc transport in MEF cells [52]. However, no detail studies on K+ homeostasis in MEF
WT, TSC1-KO, and TSC2-KO have been done. The present study was designed to fill this
gap in knowledge. Thus, an initial step was to assess the relative magnitudes of Rb+ influx
and intracellular K+ in WT, TSC1-KO, and TSC2-KO MEF cells in the absence of inhibitors
to determine the baseline values of these parameters for the three cell types [Figure 4].

22

23

Figure 4 – Rb+ influx and Ki content in WT, TSC1-KO and TSC2-KO in MEF cells
in the absence of inhibitors. Rb+ influx was determined as described in Materials and
Methods. Flux time, 5 min. Number of individual determinations (n) for WT, TSC1-KO ,
and TSC2-KO cells were n = 14, 21 and 16, respectively. Values are means ± S.E. Details
are discussed in the text.
Both the Rb+ influx and Ki content for the three cell types were statistically different
and followed the sequence WT > TSC1-KO > TSC2-KO MEF cells suggesting that cells
lacking or with abnormalities in the TSC2 gene cause more detrimental effects on K+
homeostasis than the TSC1 gene. This finding is in line with the fact that abnormalities in
the TSC2 gene are more severe and common in the TSC patient population [3, 53, 54, 55,
56].

4.2.

Studies on the Na+/K+ pump activity in WT, TSC1-KO and TSC2-KO in MEF

cells.

Due to lack of information in the literature concerning the optimal conditions to
measure the activity of NKP in WT, TSC1-KO, and TSC2-KO MEFs, the first step was to
do ouabain dose-response (ODR) curves for Rb+ influx [Figures 5 and 6] and Ki content
[Figures 7 and 8] to determine the maximal ouabain inhibitory concentration (OSmax).
Figure 5 shows inhibition of Rb+ influx at the ouabain concentrations tested (0-2.5 mM) for
the 3 cell types with the relative values of Rb+ influx following the sequence WT > TSC1KO > TSC2-KO at 0 mM ouabain whereas that of the mean values obtained by averaging
the Rb+ influx from the ODR curves for each cell type was WT ~ TSC1-KO > TSC2-KO.
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The effect of ouabain on Ki content and its averages from ODR curves done in WT,
TSC1-KO and TSC2-KO MEF cells are represented in Figures 7 and 8, respectively. As
expected for cellular K+, increasing the ouabain concentration did not affect Ki content in
WT and TSC1-KO cells (Figure 7) because K+ enters the cell through NKP but exits
through other pathways (K+ channels, NKCC, KCC and others), which are not sensitive to
ouabain. In contrast, in TSC2-KO cells, Ki content decreased with increasing ouabain
concentrations, which is unexpected in light of the findings in WT and TSC1-KO cells. In
addition, TSC2-KO cells lost about 80 % of the intracellular K+ with respect to WT cells
(Figure 8). These results albeit unexpected once more confirm that lack of or abnormalities
in the TSC2 gene appear to have detrimental effects on K+ homeostasis.
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a)

Determination of the optimal ouabain concentration for Rb+ influx and Ki

content in WT, TSC1-KO, and TSC2-KO.

Figure 5 - Ouabain-dose response (ODR) of Rb+ influx in WT, TSC1-KO, and
TSC2-KO MEF cells. Rb+ influx was determined as described in Materials and Methods.
Flux time, 5 min. Number of individual determinations (n) for WT, TSC1-KO , and
TSC2-KO cells were n = 6, 12 and 6, respectively. Values are means ± S.E. Details are
discussed in the text.
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Figure 6 – Rb+ influx averages from ouabain dose-response of Rb+ influx in WT,
TSC1-KO, and TSC2-KO MEF cells. Rb+ influx was determined as described in
Materials and Methods. Flux time, 5 min, Rb+ influx averages in this figure were
calculated as the sum of all the values of Rb+ influx at each ouabain concentration (0, 0.1,
0.5, 1, 1.5, 2, 2.5 mM) divided by the number of ouabain concentrations used (7 for each
cell line). Number of individual determinations (n) for WT, TSC1-KO, and TSC2-KO
cells were n = 6, 12 and 6, respectively. Values are means ± S.E. Details are discussed in
the text.
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Figure 7 - Effect of increasing concentration of ouabain on Ki content in WT, TSC1KO, and TSC2-KO MEF cells. Ki content was determined as described in Materials and
Methods after 5 min exposure to the indicated ouabain concentrations. Number of
individual determinations (n) for WT, TSC1-KO, and TSC2-KO cells were n = 6, 12 and
6, respectively. Values are means ± S.E. Details are discussed in the text.
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Figure 8 – Averages of Ki content from ouabain dose-response curves in WT, TSC1KO, and TSC2-KO MEF cells. Ki content was determined as described in Materials and
Methods after 5 min exposure to the indicated ouabain concentrations. Number of
individual determinations (n) for WT, TSC1-KO, and TSC2-KO cells were n = 6, 12 and
6, respectively. Values are means ± S.E. Details are discussed in the text.

As shown in figures 4-8, there were statistically significant differences in the
response of TSC1-KO and TSC2-KO cells to ouabain. However, it was not clear whether
the differences were due to the maximal ouabain inhibition, as it appears to be from the
figures, and/or to differences in the sensitivity of the mutant cells to ouabain (the half
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maximal ouabain inhibitory concentration (OIC50), Therefore, it was necessary to further
characterize the effect of the TSC1 and TSC2 genes on K+ homeostasis and the response of
the mutants to ouabain. To this end the maximal ouabain-sensitive (OSmax) and OIC50 were
determined for Rb+ influx and Ki content in the three cell types.
Figure 9 represents the calculated ouabain-sensitive (OS) Rb+ influx (NKP activity)
from ODR curves as a function of the ouabain concentration for WT, TSC1-KO and TSC2KO MEF cells. The figure shows that inhibition of NKP activity in WT and TSC1-KO cells
reach saturation at 2 mM ouabain, when the OSmax of WT cells is 121 nmoles/mg protein x
5 min whereas that of TSC1-KO is about 50 % less than that. In contrast, inhibition of NKP
by ouabain in TSC2-KO cells does not appear to saturate even at 2.5 mM ouabain and its
value at that concentration is also 50 % of the WT. Because higher doses of ouabain caused
cell detachment and were toxic to the cells, 2.5 mM was the highest dose used in this study
(Figure 9 and Table 2). A plausible explanation for these findings will be given in the
Discussion. The main message from these data is again that lack or abnormalities in the
TSC1 and TSC2 genes lead to abnormal activity of one of the major pathways involved in
K+ homeostasis, i.e. NKP.
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Figure 9 - Determination of the maximal ouabain inhibitory concentration (OSmax).
Rb+ influx was determined as described in Materials and Methods and the ouabainsensitive (OS) flux was calculated from ODR curves (see Figure 5) for each ouabain
concentration. The OSmax was determined as the lowest dose saturation was reached. Flux
time, 5 min. Number of individual determinations (n) for WT, TSC1-KO, and TSC2-KO
cells were n = 6, 12 and 6, respectively. Values are means ± S.E. Details are discussed in
the text.
Studies in rat cells have shown that the α2 isoform of the Na+/K+ ATPase has higher
affinity than α1 isoform for ouabain, in which the IC50 for α2 isoform is 0.01 – 0.5 mM and
for α1 isoform is more than 10 mM [40]. The results shown in this study appear to be no
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exception at least for the affinity for α2 isoform. To further assess the sensitivity of NKP
to ouabain in the cell models in question, the half maximal ouabain inhibitory concentration
(OIC50) was determined by assigning a value of 100 % to the OS max for each WT, TSC1KO and TSC2-KO MEF cell type and calculating the percentages for each ouabain
concentration shown in Figures 5-9.

Figure 10 and the OIC50 values were obtained. As we can see in figure10 and Table
2, the OIC50s in WT, TSC1-KO, and TSC2-KO are approximately 0.5, 0.6, and 0.6 mM,
respectively, which are not statistically significantly different given the large dispersion in
the data shown in Table 2
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Figure 10 - Determination of the half maximal ouabain inhibitory concentration
(OIC50). Rb+ influx was determined as described in Materials and Methods and the
ouabain-sensitive (OS) flux was calculated from ODR curves (see Figure 5) for each
ouabain concentration. Ouabain-sensitive Rb+ influxes were calculated as percent of the
OSmax, which was assigned arbitrarily a 100 % value. The OIC50 values were obtained
from the fitted curved at the 50 % value. Flux time was 5 min. Number of individual
determinations (n) for WT, TSC1-KO, and TSC2-KO cells were n = 6, 12 and 6,
respectively. Values are means ± S.E. Details are discussed in the text.
A summary of the ouabain effects on the Rb+ influx parameters described above is
shown in Table 2 for WT, TSC1-KO and TSC2-KO MEF cells.
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Summary of ouabain-dose-response of Rb+ Influx, OIC50 and OSmax in WT,

b)

TSC1-KO and TSC2-KO MEF cells.

Half maximal ouabain inhibitory concentration (OIC50) and maximal ouabainsensitive Rb+ influx (OSmax), which are obtained for WT, TSC1-KO, and TSC2-KO cells,
have been summarized in Table 2 to determine whether there is a difference in these
parameters between the three cell types, in addition to other statistical variables. The table
also lists the standard error (SE), range (minimum and maximum values) standard deviation
(SD), number of individual determinations (n) and independent experiments (N) performed
for WT, TSC1-KO, and TSC2-KO cells.

Cells

WT

TSC1-KO

TSC2-KO

OIC50

0.515

0.637

0.624

SE

0.17

0.14

0.42

RANGE

0.34 to 0.69

0.29 to 0.99

0.199 to 1.05

SD

0.24

0.29

0.6

OSmax

121.53

58.54 **

61.84 **

SE

12.99

4.71

12.34

RANGE

108.54 to 134.53

48.36 to 66.83

49.5 to 74.18

SD

18.37

9.42

17.45

n

6

12

6

N

2

4

2
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Table 2: Maximal ouabain-sensitive (OSmax) Rb+ influx (nmol/mg protein x 5 min)
and half maximal ouabain inhibitory concentration (OIC50, mM), statistical
parameters and number of individual determinations (n) and independent
experiments (N) performed for WT, TSC1-KO, and TSC2-KO cells.

The conclusion from these data is that the OS max was decreased by 50 % in the
mutants whereas the affinity for ouabain was not altered. The underlying factor/s leading
to a decrease in the maximal inhibition by ouabain in the absence of the TSC1 and TSC2
genes could be explained by deregulation of the mTOR pathway, as it will be explained in
the Discussion.

4.3.

Studies on NKCC activity and the effect of ouabain in WT, TSC1-KO and

TSC2-KO in MEF cells

After studying

NKP activity in WT, TSC1-KO, and TSC2-KO MEFs and

determining the optimal ouabain concentration for Rb+ influx and Ki content, which was
found to be 2 mM, the next step was to assess the impact of absence of the TSC1 and TSC2
genes and deregulation of the mTOR pathway could have on NKCC activity in these cells.
The approach followed was similar to the studies with ouabain and consisted of determining
the same parameters for bumetanide, i.e. BS max and BIC50 for Rb+ influx and Ki content at
different ouabain concentrations, 0, 0.1 and 2 mM, to learn whether there were also
abnormalities for bumetanide inhibition in the mutant cells as those found for ouabain.
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Figure 11 shows the bumetanide dose-response of Rb+ influx as a function of
bumetanide (0-50 µM) at different ouabain concentrations (0, 0.1, 2 mM) in WT MEFs.
Rb+ influx followed a hyperbolic function with no statistically different values for the three
ouabain concentrations tested in the absence of bumetanide whereas at increasing
concentrations of the inhibitor a trend for lower Rb+ influx values can be observed when
ouabain increases from 0-2 mM. In spite of the differences between the bumetanide-dose
response curves, saturation occurs at 20 µM bumetanide for the three cell types. Further
analysis of the data, represented as the averages of Rb + influx for each of the curves, is
shown in Figure 12. Results show a tendency for the averages to decrease with increasing
ouabain concentrations although not statistically significant due to the large dispersion of
the data.

The effect of ouabain on the dose-response of Ki content to increasing doses of
bumetanide (0-50) and on their averages are shown in Figures 13 and 14, respectively.
Neither the Ki content nor its averages were affected by bumetanide and ouabain in WT
cells suggesting that outward K+ movements occur through neither NKP nor NKCC under
the experimental conditions tested.
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a)

Determination of the optimal bumetanide concentration for Rb+ influx and
Ki content in WT cells.

Figure 11 – Bumetanide dose-response (BDR) of Rb+ influx in WT MEF cells and
the effect of ouabain. Rb+ influx was determined as described in Materials and Methods
as a function of bumetanide (0-50 μM), and at three different ouabain concentrations (0,
0.1 and 2 mM). Flux time, 5 min. Number of individual determinations for WT MEF cells
was n = 4. Values are means ± S.E. Details are discussed in the text.
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Figure 12 – Rb+ influx averages from bumetanide dose-response of Rb+ influx in WT
MEF cells and the effect of ouabain. Rb+ influx was determined as described in
Materials and Methods. The Rb+ influx averages were calculated from BDR curves in
Figure 11 for each ouabain concentration and plotted as shown. Flux time, 5 min. Number
of individual determinations for WT MEF cells was n = 4. Values are means ± S.E.
Details are discussed in the text.
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Figure 13 - Bumetanide dose-response of Ki content in WT MEF cells and the effect
of ouabain. Ki content was determined after 5 min of incubation in the corresponding
flux media, as described in Materials and Methods, as a function of bumetanide (0-50
μM), and at three different ouabain concentrations (0, 0.1 and 2 mM). Number of
individual determinations for WT MEF cells was n = 4. Values are means ± S.E. Details
are discussed in the text.
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Figure 14 – Ki content averages from bumetanide dose-response of Ki content in WT
MEF cells and the effect of ouabain. Ki content was determined as described in
Materials and Methods. Ki content averages at 5 min were calculated from BDR curves in
Figure 13 for each ouabain concentration and plotted as shown. Number of individual
determinations for WT MEF cells was n = 4. Values are means ± S.E. Details are
discussed in the text.

Like for ouabain, the maximal bumetanide inhibitory concentration (BS max) was
determined from the bumetanide-sensitive Rb+ influx (NKCC activity) as a function of
bumetanide in WT cells at 0, 0.1, and 2 mM ouabain (Figure 15). As it should be expected,
NKCC activity was not affected by different ouabain concentrations, and likewise the half
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maximal bumetanide inhibitory concentration (BIC50) was not affected as shown in Figure
16.

Figure 15 - Determination of the maximal bumetanide inhibitory concentration
(BSmax) in WT MEF cells and the effect of ouabain. Rb+ influx was determined as
described in Materials and Methods and the bumetanide-sensitive (BS) fluxes were
calculated from BDR curves (see Figure 11) for each bumetanide concentration. The
BSmax was determined as the bumetanide dose at which saturation was reached. Flux time,
5 min. Number of individual determinations for WT MEF cells was n = 4. Values are
means ± S.E. Details are discussed in the text.
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Figure 16 - Determination of the half maximal bumetanide inhibitory concentration
(BIC50) in WT MEF cells and the effect of ouabain. Rb+ influx was determined as
described in Materials and Methods and the bumetanide-sensitive (BS) fluxes were
calculated from BDR curves (see Figure 11) for each bumetanide concentration. The
bumetanide-sensitive Rb+ influxes were calculated as percent of BSmax, which was
assigned arbitrarily a 100 % value for all curves. The BIC50 values were obtained from
the fitted curve at the 50 % value. Flux time was 5 min. Number of individual
determinations (n) for WT MEF cells was n = 4. Values are means ± S.E. Details are
discussed in the text.
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Figure 17 - Comparison of BSmax for WT, TSC1-KO, and TSC2-KO at zero ouabain.
Rb+ influx was determined as described in Materials and Methods for each cell type in the
absence of ouabain and the bumetanide-sensitive (BS) fluxes were calculated from BDR
curves (see Figure 11) for each bumetanide concentration. The BS max was determined as
the bumetanide dose at which saturation was reached. Flux time was 5 min. Number of
individual determinations for WT, TSC1-KO and TSC2-KO MEF cells were n = 4, 6 and
10, respectively. Values are means ± S.E. Details are discussed in the text.

The same approach followed for WT cells was applied to TSC1-KO and TSC2-KO
MEF cells to determine BSmax and BIC50 at each ouabain concentration to assess whether
there was any interaction between bumetanide and ouabain while inhibiting NKCC. Figures
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17 and 18 show the bumetanide-sensitive Rb+ influx (NKCC) as a function of bumetanide
for each of the three cell types, either at 0 or 2 mM ouabain, respectively, where the BS max
can be appreciated. Unexpectedly and in contrast to what was found for WT cells, BS max
values for the mutants were significantly lower at both 0 and 2 mM ouabain. The sequence
found was WT > TSC1-KO > TSC2-KO, where the decrease for TSC1-KO and TSC2-KO
was about 30 % and 50 %, and 50 % and 75 % at 0 and 2 mM ouabain, respectively,
compared to WT. A plausible explanation for this unexpected result will be given in the
Discussion.
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Figure 18 - Comparison of BSmax for WT, TSC1-KO, and TSC2-KO at 2 mM
ouabain. Rb+ influx was determined as described in Materials and Methods for each cell
type at 2 mM ouabain and the bumetanide-sensitive (BS) fluxes were calculated from
BDR curves (see Figure 11) for each bumetanide concentration. The BS max was
determined as the bumetanide dose at which saturation was reached. Flux time was 5 min.
Number of individual determinations (n) for WT, TSC1-KO and TSC2-KO MEF cells
were n = 4, 6 and 10, respectively. Values are means ± S.E. Details are discussed in the
text.

Thus TSC2-KO cells showed larger changes than those of TSC1-KO for all the
parameters determined, and especially, for the activity of bumetanide=sensitive Rb+ influx
(NKCC) which was significantly reduced when compared not only to WT but also to TSC1KO cells (Figures 17 and 18).
A summary of bumetanide effects on Rb+ influx in WT, TSC1-KO and TSC2-KO
MEF cells and the effect of ouabain is shown in Table 3.

b)

Summary of bumetanide-dose-response of Rb+ Influx, IC50 and BSmax in
WT, TSC1-KO and TSC2-KO MEF cells and the effect of ouabain.

Half maximal bumetanide inhibitory concentration (BIC50) and maximal
bumetanide-sensitive Rb+ influx (BSmax) at 0, 0.1, and 2 mM ouabain for WT, TSC1-KO,
and TSC2-KO cells are summarized in Table 3 in order to see if there is a difference in
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these parameters between the three cell types. BIC50 is is expressed in µM and BSmax in
nmol/mg protein.

Cells

WT

TSC1-KO

TSC2-KO

Ouab.

0

0.1

2

0

0.1

2

0

0.1

2

BIC50

2.8

2.8

2.8

2.9

2.9

5.7

2.1

4.3

2.8

SE

-

-

-

0.6

0.85

2.2

0.4

2.6

1.2

SD

-

-

-

0.8

1.2

3.1

0.6

3.7

1.6

BSmax

151

159

157

112

103

87*

SE

-

-

-

15.4

34.6

1.2

2.9

14

6.8

SD

-

-

-

21.8
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1.7

4.1

120

9.7

n

4

4

4

6

6

6

10

10

10

N

1

1

1

2

2

2

4

4

4

71

37*

34**

Table 3 - Maximal bumetanide-sensitive (BSmax) Rb+ influx and half maximal
bumetanide inhibitory concentration (BIC50), statistical parameters and number of
individual determinations (n) and independent experiments (N) performed for WT,
TSC1-KO, and TSC2-KO cells at different ouabain concentrations (0, 0.1 and 2
mM).

Table 3 shows the BIC50 and BSmax for WT, TSC1-KO, and TSC2-KO MEF cells
at 0, 0.1, and 2 mM ouabain. The BIC50 for the three cell types was not statistically different
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with increasing ouabain between 0 to 2 mM, whereas the BS max did show statistically
significant differences for the effect of ouabain in a given cell type or between cell types at
a given ouabain concentration. Thus, in WT, ouabain had no effect on BS max, in contrast to
the mutants where increasing ouabain was associated with decreasing BS max. Larger
changes were observed for TSC2-KO compared to TSC1-KO cells. In addition, the
magnitude of the BSmax values followed the sequence WT > TSC1-KO > TSC2-KO, which
resembles the trend observed for most of the variables determined in this study and where
absence of the TSC2 gene appears to cause a more abnormal deregulation of the mTOR
pathway than the absence of TSC1 [3, 53, 55, 56].

One of the aims of this study was to assess the relative activities of the main
pathways for K+ transport that are known to be involved in cell volume regulation,
migration and proliferation. These are NKP, NKCC and KCC. Another purpose was oto
assess whether murine embryonic fibroblasts behave as adult cells in terms of their ion
transport properties and to understand which of the two genes, TSC1 or TSC2, have a major
impact if any on K+ homeostasis as determined by Rb+ influx and Ki content. The studies
described above were designed to provide the optimal ouabain and bumetanide
concentrations for the three cell types, WT, TSC1-KO and TSC2-KO MEF cells to
accomplish this goal. The conclusion from such studies is that 2 mM ouabain and 20 μM
bumetanide were the optimal concentrations to further assess the activity of the
aforementioned pathways under more physiological conditions.
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Figure 19 shows the Rb+ influx pathways measured at optimal ouabain (2 mM) and
bumetanide concentrations (20 μM) for WT, TSC1-KO and TSC2-KO MEF cells. Rb+
influx was determined as described in Materials and Methods in the presence and absence
of Cl-, ouabain and bumetanide to determine the activities of NKP, NKCC and KCC. In the
upper panel, the Rb+ influx was measured in chloride (Cl), chloride + 2 mM ouabain (ClO),
chloride + 2 mM ouabain + 20 µM bumetanide (ClOB) and sulfamate + 2 mM ouabain +
20 µM bumetanide (SOB). In the lower panel, the calculated NKP, NKCC and KCC
activities are represented for each cell type. It is clear from the figure that the major
difference for all the variables studied appears in TSC2-KO cells where Rb+ influx in all
the media, ± Cl- and ± inhibitors, and through the three transporters in question is
significantly diminished when compared to both WT and TSC1-KO. For the latter, the only
difference observed was a decrease in ClOB and consequently, a decrease in KCC.
However, the NKCC activity, although elevated was not statistically different from that in
WT cells. In these cells, NKP and NKCC contributed to 92 % of the total Rb+ influx
whereas only 8 % of the influx occurred through KCC. The major contributor for Rb+ influx
in WT cells was NKCC (68 %) followed by NKP (24 %) and KCC (8%).

According to the hypothesis tested in this study, TSC1-KO and TSC2-KO MEF
cells should have increased mTORC1 activity [44]. Increased mTORC1 activity affects the
activity of NKCC as shown in mammalian skeletal muscle cells [41, 42, 44] and the
expression of KCC as shown in human cells [43, 44]. In fact, the baseline NKCC activity
in TSC1-KO cells was 90 % of the total Rb+ influx followed by NKP (5 %) and KCC (5
%), in contrast to the values observed in WT cells. However, the total Rb + influx through
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NKP, NKCC, and KCC in WT and TSC1-KO cells was the same, whereas that of TSC2KO was less than 40 % when compared to WT and TSC1-KO and shown in [Fig.19].

In conclusion, these findings are in agreement with studies on the effect of
deregulation of the mTOR pathway on NKCC activity and KCC expression [41, 42, 43],
and will be further analyzed in the Discussion.
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4.4.

Rb+ influx and Ki content in WT, TSC1-KO and TSC2-KO in MEF cells.
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Figure 19 – Rb+ influx pathways at optimal ouabain and bumetanide concentrations
for WT, TSC1-KO and TSC2-KO MEF cells. Rb+ influx was determined as described
in Materials and Methods in the presence and absence of Cl-, ouabain and bumetanide to
determine the activities of NKP, NKCC and KCC at optimal inhibitor concentrations, 2
mM ouabain and 20 uM bumetanide. Upper panel: Cl, ClO, ClOB and SOB. Lower
panel: NKP, NKCC and KCC for each cell type. Flux time was 5 min and Rb+ influx
components and transporters were calculated as described in Materials and Methods.
Number of individual determinations (n) for WT, TSC1-KO and TSC2-KO MEF cells
were n = 12, 6 and 12, respectively. Values are means ± S.E. Details are discussed in the
text.
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Figure 20: Ki content at optimal ouabain and bumetanide concentrations for WT,
TSC1-KO and TSC2-KO MEF cells. Ki content was determined as described in
Materials and Methods in the presence and absence of Cl-, ouabain and bumetanide at
optimal inhibitor concentrations, 2 mM ouabain and 20 μM bumetanide in the
corresponding media: Cl, ClO, ClOB and SOB for each cell type. Flux time was 5 min.
Number of individual determinations for WT, TSC1-KO and TSC2-KO MEF cells were n
= 12, 6 and 12, respectively. Values are means ± S.E. Details are discussed in the text.

Figure 20 shows Ki content in WT, TSC1-KO and TSC2-KO MEF cells under the
same conditions as described in Figure 19. In the mutant cells, Ki content was surprisingly
low (~40 % in TSC1-KO and ~60 % in TSC2-KO lower compared to WT cells). The loss
of K+ occurs through none of the transporters studied, as shown in the figure, and may be
lost perhaps through an unidentified K+ channel that requires further exploration.

4.5.

Proposed model of the factors affecting Ki homeostasis in TSC1-KO and TSC2-

KO MEFs.

According to our hypothesis, when the TSC1 gene in MEF cells is mutated or
knocked out, the mTORC1 activity increases [3-6] and consequently affects NKCC activity
and KCC expression [3 - 6, 41 - 43]. As a result, highly active mTORC1 causes activation
of NKCC and inhibition of KCC [4 - 6].
This model explains the effect of the TSC1 and TSC2 genes on K+ homeostasis
through the mTOR pathway in MEF cells. In the upper panel, the mutated TSC1 gene
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increases mTORC1 activity and it may decrease NKP activity (Table 2 and Figs. 9 and 19).
A decrease in NKP activity may be explained by consumption of ATP by mTORC1. ATP
is needed in the NKP cycle to transport Na+ and K+, [44 - 47]. NKCC and KCC activities
were statistically significantly increased and decreased, respectively, in TSC1-KO cells due
to the effect of a highly active mTORC1 (Figs. 19 and 20). Lastly, the total magnitude of
Rb+ (K+) influx through the three pathways was similar to that found in WT cells (Fig. 19)
see the upper panel of (Fig. 21).

On the other hand, as shown in the lower panel of this model, a mutated TSC2 gene
increases the mTORC1 activity, as it occurs in TSC1-KO cells, and it may decrease the
NKP activity (Table 2 and Figs. 9 and 19), as seen in TSC1-KO cells (Figs. 19 and 20).
However, the striking difference between the two mutants is the low magnitude of Rb+ (K+)
influx and Ki content in TSC2-KO cells (Figs. 4 – 9, Table 2 and 3) compared to WT and
TSC1-KO cells (Figs. 19, 20).
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Figure 21. Hypothetical model of the factors affecting Ki homeostasis in TSC1-KO
and TSC2-KO MEFs. 1 = activation of mTORC1 as a result of mutation in the TSC1
or TSC2 genes. Higher activity of mTORC1 causes 2 = less NKP activity, 3 =
activation of NKCC, and 4 = less expression of KCC. Big K+ means higher
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intracellular potassium in TSC1-KO cells (upper panel). Small K+ means lower
intracellular potassium in TSC2-KO cells (lower panel).

5.

Discussion

The TSC1-TSC2 complex plays a crucial role in the inhibition of mTORC1 and
activation of mTORC2, and ultimately in the regulation of NKCC activity and KCC
expression through a negative feedback process involving S6K1, Akt, IGF-1, and several
other proteins [4, 5, 6, 41, 42, 43] because mTORC1 phosphorylates S6K1, while
(mTORC2) phosphorylates Akt [3, 5]. Highly active S6K1 causes feedback inhibition of
IRS-1 leads to inability of insulin or IGF1 to activate PI3K and subsequently Akt [3, 4, 5,
25].

The present study investigated the role of the TSC1 and TSC2 genes, and indirectly,
of the mTOR pathway on cellular K+ homeostasis in WT, TSC1-KO, and TSC2-KO MEF
cells. The approach was to measure Rb+ influx and Ki content to assess the impact of these
genes on the K+ transporters, NKP, NKCC and KCC, known to be involved in K +
homeostasis, cell volume regulation, proliferation, migration and in other cellular metabolic
processes [1, 32, 43, 51, 58]. Our main findings show that in MEF cells overall, the
activities of the transporters studied followed the sequence NKCC > NKP > KCC, which
resemble findings in adult murine cells. However, there were differences in their relative
magnitudes within and across cell types. For instance, in the mutants, the activities of NKP
and KCC were statistically lower than in WT cells whereas NKCC was 25 % greater in
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TSC1-KO than in WT, and in TSC2-KO cells, where it was about 70 % lower than for both
WT and TSC1-KO cells (Fig.19).

The decreased NKP activity in knockout cells, about 50% less than in WT cells
(Table 2 and Figs. 9 and 19), may be explained by extensive consumption of ATP, which
is needed in the NKP cycle to transport Na+ and K+, by mTORC1. As a matter of fact,
TSC1-KO and TSC2-KO cells are considered models of increased mTORC1 activity [44,
45, 46, 47]. However, the averages of Rb+ influx and Ki content in TSC2-KO cells are
considerably less than in TSC1-KO and WT cells. A plausible explanation may lie on the
magnitude of NKCC activity in TSC1-KO compared to TSC2-KO which can transport Rb+
(K+) inward or outward depending on the gradient. Further studies on NKCC and KCC are
needed to address this particular point.

The mTORC1 activity is increased in cells lacking either the TSC1 (hamartin)
and/or TSC2 (tuberin) genes, which in turn affect the activity of NKCC and the expression
of KCC [41, 43, 44], through a negative feedback inhibition of insulin receptor substrate 1
(IRS-1), as shown in mammalian skeletal muscle and human cells. Therefore, the
mTORC1-driven feedback inhibition of IRS-1 prevents insulin or IGF1 to activate PI3K
and subsequently Akt [41 - 43, 45]. Thus, defects in the TSC1-TSC2 complex activate
mTORC1 and S6K1 constitutively. This activation of S6K1 hyper phosphorylates and
degrades IRS-1. As a result of the IRS-1 degradation, the PI3K signaling will be attenuated.
PI3K affects the phosphorylation of Akt, so expression of KCC will be decreased and
activity of NKCC will be increased [41 - 43, 45] because KCC expression and NKCC
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activity are dependent on Akt in opposite ways which means when Akt is attenuated, KCC
expression decreases and NKCC activity increases.
In our results the baseline NKCC activity was 90 % of the total Rb+ influx, followed
by NKP (5 %) and KCC (5 %) in TSC1-KO cells as shown in (fig. 19), in contrast to the
values observed in WT cells These findings are in agreement with reports in mammalian
skeletal muscle and human cells where the activities of NKCC and KCC were increased
and decreased, respectively, in cells lacking the TSC1 and TSC2 genes. Likewise, in TSC2KO cells, albeit possessing lower NKCC and KCC activities than in TSC1-KO cells, NKCC
was the predominant pathway, whereas KCC was the minor route for K+ movements (Fig.
19), fulfilling the predictions of our hypothesis.

According to various studies on the affinity of ouabain for NKP in human cells
(HEK293), the concentrations of ouabain to inhibit NKP are in the µM range (~ 0.1 mM)
[57, 58]. However, in mouse cells, the concentrations are in the mM range (~ 1 mM) [59].
In our studies, in order to determine the optimal ouabain concentration to inhibit NKP in
MEF cells, we have done ouabain dose-response (ODR) curves for Rb+ influx [Figures 5
and 6] and Ki content [Figures 7 and 8] and we found that the OIC50 was ~ 0.5 mM for both
WT and mutant cells and OSmax was around 121 nmoles/mg protein for WT cells, but for
the mutants cells the OSmax was ~ 60 nmoles/mg protein (Table 2). Thus, the optimal
ouabain concentration in these cells was 2 mM [Figures 5 and 9].
Therefore, the relative values of Rb+ influx followed the sequence WT > TSC1-KO
> TSC2-KO at 0 mM ouabain, whereas that of the mean values obtained by averaging the
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Rb+ influx from the ODR curves for each cell type was WT ~ TSC1-KO > TSC2-KO
[Figures 6 and 8]. In addition, there was no difference in the OIC50s (~ 0.5 mM) (Table 2)
and for the OSmax the sequence was WT > TSC1-KO ~ TSC2-KO (Table 2). As a
conclusion, ouabain binds with low affinity to NKP in MEF cells compared to human
erythrocytes (IC50 ~ 4 x 10-8 M) [66]. Our results are also in agreement with findings in
adult murine cells.

On the other hand, the bumetanide concentrations to block NKCC in primary rat
neurons cells are in the µM range. For instance, at ~ 10 µM there is strong inhibition of
NKCC [60]. However, in our studies with MEF cells, the actual values were not known.
Thus, to determine the optimal bumetanide concentration, we have done bumetanide doseresponse (BDR) curves for Rb+ influx [Figures 11 and 12] and Ki content [Figures 13 and
14] and found that 20 µM bumetanide was the optimal concentration to maximally inhibit
NKCC at 0, 0.1, and 2 mM ouabain in the three cell types [Figs. 11, 15, 17, and 18]. In
addition, we determined the maximal bumetanide-sensitive Rb+ influx (BSmax) and the half
maximal bumetanide inhibitory concentration (BIC50) at different ouabain concentrations
[Figs. 15 - 18]. The relative values of Rb+ influx followed the sequence WT > TSC1-KO >
TSC2-KO at 0, 0.1, and 2 mM ouabain whereas that of the mean values obtained by
averaging the Rb+ influx from the ODR curves for each cell type was WT > TSC1-KO >
TSC2-KO at 0, 0.1, and 2 mM ouabain. In conclusion, while ouabain did not affect the
BIC50 as a function of its concentration for the three cell types (~ 3 µM), it did affect the
maximal activity of NKCC both as a function of ouabain concentration in the mutants and

58

in TSC2-KO more than in TSC1-KO, but not in WT cells (figures 17 and 18 and Table 3).
Also, mouse cells needs slightly more bumetanide concentration (20 µM) to inhibit NKCC
comparing to rat neuron cells (10 µM) which means that MEF cells have merely less affinity
for bumetanide compared to rat cells [60].

In conclusion, the major findings in this study support the hypothesis proposing that
the TSC1 and TSC2 genes, which control cell processes through the mTOR pathway, are
important for K+ homeostasis where the activities of NKP were reduced, NKCC increased
and KCC decreased, according to expectations and the proposed model (figures 21).
Furthermore, cells lacking the TSC2 gene showed more striking changes concerning K +
homeostasis than those seen in cells lacking the TSC1 gene (Figures; 4, 6, 8, 17, 18, 19, 20,
and Tables 2 and 3). Furthermore, the distinct abnormalities in ion transport of TSC2-KO
compared to TSC1-KO and WT cells parallels the pathological manifestation and incidence
of tuberous sclerosis complex in the human population [3, 53, 54, 55, 56].
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Abbreviations:

AMPK, AMP-activated kinase which is an enzyme that plays a role in cellular
energy homeostasis; 4E-BP, eIF4E binding protein is a protein that play an important
role in the control of protein synthesis, survival, and cell growth, eIF4E, eukaryotic
initiation factor 4E is a cap-binding protein that participates in recruitment of mRNA
to the ribosome; Mnk1, mitogen-activated protein kinase-interacting kinase 1;
mTORC1, mammalian target of rapamycin complex 1; mTORC2, mammalian target of
rapamycin complex 2; PDK1, phosphoinositide-dependent protein kinase 1;
PtdIns(3,4,5)P3,

phosphatidylinositol-3,4,5-triphosphate;

PtdIns(4,5)P2,

phosphatidylinositol-4,5-bisphosphate; raptor, regulatory associated protein of tor;
rictor, rapamycin-insensitive companion of mtor; S6, ribosomal protein S6; S6K,
p70S6 kinase; S473, serine 473; T308, threonine 308; TSC, tuberous sclerosis complex;
RVD, regulatory volume decrease; RVI, regulatory volume increase; NKP, Na+/K+
pump; NKCC, Na+-K+-2Cl- co-transporter; KCC, K-Cl cotransport; mTOR,
mammalian target of rapamycin; TSC1, tuberous sclerosis complex 1; TSC2, tuberous
sclerosis complex 2; MEFs, mouse embryonic fibroblasts; MEFs WT, mouse
embryonic fibroblasts wild type; MEFs TSC1-KO, mouse embryonic fibroblaststuberous sclerosis complex 1 knockout; MEFs TSC2-KO, mouse embryonic
fibroblasts-tuberous sclerosis complex 2 knockout; CDK1, cyclin-dependent kinase 1;
GSK3β, glycogen synthase 3β; ERK2, extra cellular related kinase 2; MK2, mitogenactivated protein kinase–activated protein kinase 2; AKT/PKB, protein kinase b; RSK1,
p90

ribosomal

s6

kinase

1;

GAP,

phosphatidylinositol-4,5-bisphosphate

GTP-ase
3-kinase;

activating
AICAR,

protein;

PI3K,

5-amino-4-

imidazolecarboxamide ribose; Rheb, RAS homolog enriched in brain; FRAP1, fk506binding protein 12-rapamycin-associated protein 1; mLST8, mammalian lethal with
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sec13 protein 8; mSIN1, mammalian stress-activated protein kinase (sapk)-interacting
protein 1; FKBP12, FK506 binding protein; FRB, FKBP12-rapamycin binding; IGF-1,
insulin-like growth factor 1; IGF-2, insulin-like growth factor 2; S6K1, ribosomal
protein s6 kinase beta-1; ROS, reactive oxygen species; ATP, adenosine triphosphate;
slc12a2, solute carrier family 12 (sodium/potassium/chloride transporter), member 2;
slc12a1, solute carrier family 12 (sodium/potassium/chloride transporter), member 1;
PKC, protein kinase c; PKA, protein kinase a; CNS, central nervous system.
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